BVS (Bioventus) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BVS Bioventus Inc BVS
66 GF Score
Price $12.32
GF Value $6.81
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bioventus Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

BVS
66GF Score
Bioventus Inc BVS
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioventus (BVS) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventus stock appears to be overvalued. The current stock price of $12.32 is trading 80.9% above its estimated GF Value™ of $6.81. GuruFocus considers Bioventus to be Significantly Overvalued.

Key valuation signals for BVS:

  • Interest Received:
  • GF Value™: $6.81 vs. price of $12.32 (80.9% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the BVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventus Business Description

Other Exchanges 4B8:Germany
Address 4721 Emperor Boulevard, Suite 100, Durham, NC, USA, 27703
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
66GF Score

Get the complete analysis for BVS

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.32
Price
$6.81
GF Value